help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on November 7, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1864
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/2/405    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosner, W.
Right arrow Articles by Raff, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosner, W.
Right arrow Articles by Raff, H.

Submitted on August 24, 2006
Accepted on October 30, 2006

UTILITY, LIMITATIONS AND PITFALLS IN MEASURING TESTOSTERONE: An Endocrine Society Position Statement

William Rosner*, Richard J. Auchus, Ricardo Azziz, Patrick M. Sluss, and Hershel Raff

St Luke's/Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, NY 10019; Division of Endocrinology and Metabolism, UT Southwestern Medical Center, Dallas, TX 75390; Center for Androgen Related Disorders and Dept. of Ob/Gyn, Cedars-Sinai Medical Center and Dept. of Ob/Gyn and Dept. of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90048; Reproductive Endocrine Unit (Department of Medicine) and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Endocrine Research Laboratory, Aurora St. Luke's Medical Center, Division of Endocrinology, Metabolism and Clinical Nutrition, Medical College of Wisconsin, Milwaukee, WI 53215

* To whom correspondence should be addressed. E-mail: wr7{at}columbia.edu.

Objective: To evaluate the current state of clinical assays for total and free testosterone.

Participants: The five participants were appointed by the Council of the Endocrine Society and charged with attaining the objective using published data and expert opinion.

Evidence: Data were gleaned from published sources via online databases (principally PubMed, Ovid MEDLINE, Google Scholar), the College of American Pathologists, and the clinical and laboratory experiences of the participants.

Consensus Process: The statement was an effort of the Committee and was reviewed in detail by each member. The Council of the Endocrine Society reviewed a late draft and made specific recommendations.

Conclusions: Laboratory proficiency testing should be based on the ability to measure accurately and precisely samples containing known concentrations of testosterone, not only upon agreement with others using the same method. When such standardization is in place, normative values for total and free testosterone should be established for both genders and for children taking into account the many variables that influence serum testosterone concentration.
Key words: testosterone • free testosterone • assay • hypogonadism • sex hormone binding globulin • polycystic ovary syndrome




This article has been cited by other articles:


Home page
 Menopause IntHome page
C. L Shufelt and G. D Braunstein
Testosterone and the breast
Menopause Int, September 1, 2008; 14(3): 117 - 122.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.O. Goodarzi, J.F. Maher, J. Cui, X. Guo, K.D. Taylor, and R. Azziz
FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome
Hum. Reprod., August 29, 2008; (2008) den324v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Moll, J.C. Korevaar, P.M.M. Bossuyt, and F. van der Veen
Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?
Hum. Reprod., August 1, 2008; 23(8): 1830 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. M. Thienpont, K. Van Uytfanghe, S. Blincko, C. S. Ramsay, H. Xie, R. C. Doss, B. G. Keevil, L. J. Owen, A. L. Rockwood, M. M. Kushnir, et al.
State-of-the-Art of Serum Testosterone Measurement by Isotope Dilution-Liquid Chromatography- Tandem Mass Spectrometry
Clin. Chem., August 1, 2008; 54(8): 1290 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. A. Platz
Low Testosterone and Risk of Premature Death in Older Men: Analytical and Preanalytical Issues in Measuring Circulating Testosterone
Clin. Chem., July 1, 2008; 54(7): 1110 - 1112.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S A Paul Chubb, Z. Hyde, O. P Almeida, L. Flicker, P. E Norman, K. Jamrozik, G. J Hankey, and B. B Yeap
Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study
Eur. J. Endocrinol., June 1, 2008; 158(6): 785 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. F. Witchel
Ontogeny of Polycystic Ovary Syndrome: A Creative Approach
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1576 - 1578.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Mueller, L. J. Gooren, S. Naton-Schotz, S. Cupisti, M. W. Beckmann, and R. Dittrich
Prevalence of Polycystic Ovary Syndrome and Hyperandrogenemia in Female-to-Male Transsexuals
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1408 - 1411.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. A. Martin, R. J. Chang, D. A. Ehrmann, L. Ibanez, R. A. Lobo, R. L. Rosenfield, J. Shapiro, V. M. Montori, and B. A. Swiglo
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1105 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. S. Swerdloff and C. Wang
Free Testosterone Measurement by the Analog Displacement Direct Assay: Old Concerns and New Evidence
Clin. Chem., March 1, 2008; 54(3): 458 - 460.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. S. Fritz, A. J.S. McKean, J. C. Nelson, and R. B. Wilcox
Analog-Based Free Testosterone Test Results Linked to Total Testosterone Concentrations, Not Free Testosterone Concentrations
Clin. Chem., March 1, 2008; 54(3): 512 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Ann Clin BiochemHome page
R. Azziz
Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome
Ann Clin Biochem, January 1, 2008; 45(1): 3 - 5.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Handelsman
Update in Andrology
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4505 - 4511.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. D. Braunstein
The Endocrine Society Clinical Practice Guideline and The North American Menopause Society Position Statement on Androgen Therapy in Women: Another One of Yogi's Forks
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4091 - 4093.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller
Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome
Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. D. Braunstein
Gynecomastia
N. Engl. J. Med., September 20, 2007; 357(12): 1229 - 1237.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Z. Stanczyk, J. S. Lee, and R. J. Santen
Standardization of Steroid Hormone Assays: Why, How, and When?
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1713 - 1719.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Mueller, F. Kiesewetter, H. Binder, M. W. Beckmann, and R. Dittrich
Long-Term Administration of Testosterone Undecanoate Every 3 Months for Testosterone Supplementation in Female-to-Male Transsexuals
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3470 - 3475.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Morgentaler
Guideline for Male Testosterone Therapy: A Clinician's Perspective
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 416 - 417.
[Full Text] [PDF]

eLetters:

Read all eLetters

Spurious increases in serum testosterone concentrations related to phenylbutazone therapy
Bernard Uzzan, et al.
JCEM Online, 15 Feb 2007 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society